[Selective serotonin reuptake inhibitors and mammary pathologies].
作者信息
Shchepotin I B, Zotov A S, Dobzhenko M N
出版信息
Vopr Onkol. 2010;56(4):393-7.
PMID:20968014
Abstract
摘要
相似文献
1
[Selective serotonin reuptake inhibitors and mammary pathologies].[选择性5-羟色胺再摄取抑制剂与乳腺疾病]
Vopr Onkol. 2010;56(4):393-7.
2
[New antidepressive agents].[新型抗抑郁药]
Union Med Can. 1995 Nov;124(3):8-13.
3
[The transfer of selective serotonin reuptake inhibitors to human milk].[选择性5-羟色胺再摄取抑制剂向母乳中的转移]
Tidsskr Nor Laegeforen. 2001 Jan 20;121(2):199-203.
4
Neonatal complications after intrauterine exposure to SSRI antidepressants.宫内暴露于选择性5-羟色胺再摄取抑制剂（SSRI）类抗抑郁药后的新生儿并发症。
Prescrire Int. 2004 Jun;13(71):103-4.
5
[Differential features of SSRIs].[选择性5-羟色胺再摄取抑制剂的差异特征]
Rev Med Univ Navarra. 1997 Oct-Dec;41(4):245-57.
6
[Severe withdrawal symptoms with fever upon stopping paroxetine].
Ned Tijdschr Geneeskd. 1999 Aug 28;143(35):1795; author reply 1795-6.
7
A large-scale observational comparison of antidepressants and their effects.抗抑郁药及其疗效的大规模观察性比较。
J Psychiatr Res. 2024 Oct;178:219-224. doi: 10.1016/j.jpsychires.2024.08.001. Epub 2024 Aug 3.
8
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.使用选择性5-羟色胺再摄取抑制剂治疗自闭症的功能障碍。
Ann Pharmacother. 2004 Sep;38(9):1515-9. doi: 10.1345/aph.1D543. Epub 2004 Aug 3.
9
[Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].与使用选择性5-羟色胺再摄取抑制剂（SSRI）相关的戒断症状
Ugeskr Laeger. 1998 Dec 7;160(50):7291-3.
10
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].[氟伏沙明治疗酒精依赖中的抑郁障碍：随机开放标签对照研究结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(12):57-62. doi: 10.17116/jnevro202112112157.
Zotero 插件